Fortis Healthcare Share Price in Focus; Reappoints Dr. Ashutosh Raghuvanshi as Managing Director and CEO

Fortis Healthcare Limited has announced the reappointment of Dr. Ashutosh Raghuvanshi as the Managing Director and Chief Executive Officer for an additional 2-year term, as per the exchange filings.  

This decision was made during the board meeting held on July 8, 2026, and is subject to shareholder approval. 

Fortis Healthcare’s Board Meeting Outcome 

On July 8, 2026, the Board of Directors of Fortis Healthcare Limited convened to discuss key matters, including the reappointment of Dr. Ashutosh Raghuvanshi.  

The board recommended extending his tenure as Managing Director and CEO for another 2 years, effective from March 19, 2027. This decision underscores the board's confidence in Dr. Raghuvanshi's leadership and his contributions to the company's growth. 

About Dr. Ashutosh Raghuvanshi 

Dr. Ashutosh Raghuvanshi, aged 64, holds an MBBS and an M.S. in General Surgery from Mahatma Gandhi Institute of Medical Sciences, Wardha, and an M.Ch. in Cardiac Surgery from Bombay Hospital Institute of Medical Sciences.  

With over 38 years of experience in the healthcare sector, he has been instrumental in steering the growth of Fortis Healthcare. Prior to joining Fortis, Dr. Raghuvanshi served in various leadership roles at Narayana Health, a prominent healthcare chain. 

Read More: HPCL Share Price in Focus; Company Appoints Srividya Venkataraman as Chief Financial Officer! 

About Fortis Healthcare 

Fortis Healthcare is a leading integrated healthcare service provider in India and the Asia-Pacific region. Headquartered in Gurugram, it operates a vast network of 36 medical facilities, over 6,000 operational beds, and 400+ diagnostic centers across India, the UAE, and Sri Lanka 

Fortis Healthcare Share Price Performance 

As of July 08, 2026, at 3:30 PM, Fortis Healthcare share price on NSE was trading at ₹941.75, down by 3.10% from the previous closing price. 

Conclusion 

Fortis Healthcare's board has approved the reappointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for 2 years from March 19, 2027. His extensive experience and leadership have been pivotal to the company's growth, as acknowledged by the board. 

Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.